SCHEMBL20127476

SCHEMBL20127476

c1ccc2c(c1)oc1ccc3cc(-c4c5ccccc5c(-c5ccc6c7ccccc7c7ccccc7c6c5)c5ccccc45)ccc3c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
HCRTR1 O43613 1/20 0.37
NPC1 O15118 3/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 3/20 0.37
AHR P35869 2/20 0.37
RAB9A P51151 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ABCG2 Q9UNQ0 3/20 0.36
PAX8 Q06710 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127489 0.96 CASP3 (0.40) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20127495 0.94 PLA2G2A (0.42) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20127488 0.94 MAPT (0.44) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20127469 0.91 TDP1 (0.48) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20127484 0.91 AHR (0.44) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20127474 0.91 TDP1 (0.50) TDP1L3MBTL1NPC1KDM4EALDH1A1
SCHEMBL20127342 0.91 TDP1 (0.43) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20127334 0.91 TDP1 (0.46) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20127496 0.90 KDM4E (0.41) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL20412618 0.90 ESR1 (0.42) TDP1L3MBTL1CASP3SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 TDP1 3427/4885L3MBTL1 1670/4885CASP3 3455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.